1 Min Read
Dec 1 (Reuters) - ELANIX BIOTECHNOLOGIES AG:
* SIGNS AGREEMENT WITH DERMACON TO DEVELOP PROGENITOR CELL MEDICAL DEVICES TO ACCELERATE WOUND HEALING Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.